ePrints

Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon‐like peptide‐1 receptor agonists: a systematic literature review and indirect treatment comparison.

Lookup NU author(s): Emeritus Professor Philip Home

Downloads

• Published version [.pdf]

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).

Publication metadata

Author(s): Home PD, Aroda VR, Blonde L, Guyot P, Shaunik A, Fazeli MS, Goswami H, Kalra S, Pourrahmat M-M

Publication type: Article

Publication status: Published

Journal: Diabetes, Obesity and Metabolism

Year: 2020

Volume: 22

Issue: 11

Pages: 2170-2178

Print publication date: 01/11/2020

Online publication date: 06/07/2020

Acceptance date: 03/07/2020

Date deposited: 21/03/2022

ISSN (print): 1462-8902

ISSN (electronic): 1463-1326

Publisher: Wiley-Blackwell Publishing Ltd

URL: https://doi.org/10.1111/dom.14136

DOI: 10.1111/dom.14136

Altmetrics

Funding

Share